Topical Gel for Epidermolysis Bullosa Shows Ongoing Benefit

Patients with EB experienced substantial reductions in affected skin area with continued use of the bark-derived topical agent oleogel-S10 in an open-label extension study.

Related Keywords

Glasgow ,Glasgow City ,United Kingdom ,Dublin ,Ireland ,New York ,United States ,Scotland ,British ,Ramank Madan ,Tracey Cunningham ,Northwell Health ,European Medicines Agency ,Drug Administration ,Amryt Pharmaceuticals ,British Association Of Dermatologists ,British Association ,Medscape Medical News ,Epidermolysis Bullosa Disease Activity ,Scarring Index ,Wound Management ,Blister ,Tulla ,Epidermolysis Bullosa ,Topical Medications ,Wound ,Wound Healing ,Pruritus ,Pruritis ,Pitch ,Acute Bacterial Skin Infection ,Cute Bacterial Skin And Structure Infection ,Bsssi ,Anemia ,Us Food And Drug Administration ,Nited States Food And Drug Administration ,Fda ,Hematology ,Skin And Soft Tissue Infection ,Wound Infection ,